NHS Losartan Alert: 8 Symptoms Requiring 999 Call
The NHS warns losartan, a common blood pressure drug, isn't suitable for everyone. Know the 8 critical signs requiring a 999 call. Check if you're at risk.
The NHS warns losartan, a common blood pressure drug, isn't suitable for everyone. Know the 8 critical signs requiring a 999 call. Check if you're at risk.
Children as young as ten in a controversial NHS-backed puberty blocker trial will be advised to consider freezing eggs or sperm. Over 100 MPs demand Health Secretary Wes Streeting halts the project.
Chloe Cole, 21, testified on the lasting health impacts of her teenage gender transition, supporting new HHS rules to protect children from irreversible procedures. Read her full story.
A UK sociologist warns that bans on puberty blockers and hormone therapy for trans youth in Queensland and New Zealand, mirroring a UK policy, are causing 'abject misery' and will lead to suicides. Read the full investigation.
NHS England plans to train GPs as gender medicine specialists to prescribe hormones, aiming to cut huge waiting lists. New rules also raise referral age to 18.
Queensland's health minister confirms a ban on puberty blockers for new patients will continue until a UK NHS trial concludes in 2031, despite review findings. Read the full story.
The NHS issues a vital alert for millions taking the common heart drug Bisoprolol. Know the three serious side effects that require immediate emergency action.
Health Secretary Wes Streeting tells MPs children cannot give informed consent for puberty blockers trial, as 107 MPs and peers demand a halt to the 'dangerous mistake'.
Australia's TGA issues safety warning after 85 reports link Ozempic, Mounjaro & similar drugs to suicidal ideation and self-harm. Patients urged to monitor mental health.
Columnist Sarah Vine condemns the use of puberty blockers on children as a dangerous experiment. She questions Labour's Wes Streeting over his stance. Read the full analysis.
A new £10.7m NHS clinical trial will ask participants as young as 12 if they identify as 'two spirit', amid criticism from gender-critical health practitioners. Read the full details.
Conservative leader Kemi Badenoch urges Health Secretary Wes Streeting to stop an experimental trial of puberty blockers on children, citing safety concerns and ideological opposition.
The UK's ban on puberty blockers for gender dysphoria faces a new chapter as an NHS clinical trial is approved. Explore the debate on safety, ethics, and the future of youth gender care.
Controversial NHS trial will study effects of puberty blockers on children's brains. Professor Emily Simonoff says she's 'very proud' to lead landmark research amid legal threats.
NHS England initiates two clinical trials to assess the impact of puberty blockers on young people with gender incongruence, following the Cass review's findings of insufficient evidence.
NHS England launches two clinical trials investigating puberty blockers' effects on young people with gender incongruence. Findings expected in 4+ years following Cass review concerns.
The NHS is launching a controversial clinical trial, giving puberty blockers to 226 children as young as ten. Critics call it 'outrageous' while researchers insist on rigorous safety monitoring. Read the full story.
New Zealand halts new puberty blocker prescriptions for transgender youth, citing insufficient evidence. Critics warn of severe mental health impacts. Learn more about the global debate.
New Zealand halts new puberty blocker prescriptions for transgender youth, citing insufficient evidence. Critics warn of devastating mental health impacts. Read the full story.
A concerned mother shares her heartbreaking story about her teenage daughter being prescribed puberty blockers following brief NHS appointments, raising serious questions about youth gender care protocols.
After successfully overturning Queensland's controversial puberty blocker ban, a determined woman faces renewed battle as the LNP government reinstates the legislation, sparking fresh debates over transgender healthcare rights in Australia.
In a historic judgment with global implications, Australia's Federal Court has ruled that puberty blockers for transgender children are no longer considered 'therapeutic treatment', sparking intense debate across medical and LGBTQ+ communities.
In a groundbreaking healthcare policy shift, Queensland has suspended access to puberty blockers for transgender children, sparking a fierce court battle initiated by a determined mother fighting for her child's treatment.
Exclusive: Labour supports NHS England's decision to halt routine puberty blocker prescriptions outside research settings, marking a significant shift in youth gender care policy.
Chancellor Rachel Reeves vows to fast-track Gatwick Airport's second runway, siding with 'builders not blockers' to boost UK economic growth and create new jobs, despite environmental opposition.
Ex-broadcasting boss George Savvides calls on commercial networks to implement mandatory ad-skipping technology, branding the current flood of betting ads a 'public health crisis'.
EXCLUSIVE: A major new study reveals a shocking link between widely prescribed beta-blockers and a dramatic rise in suicide and self-harm attempts. Experts issue an urgent call for patient review and heightened monitoring.
A growing number of Britons are using the heart drug propranolol 'off-label' to manage anxiety symptoms. Discover how this beta blocker works and why it's sparking both hope and debate in the UK's mental health landscape.
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
Groundbreaking research from Germany uncovers a critical gender health gap, finding women on common heart drugs face a significantly higher risk of death than men. Experts call for immediate review of prescription guidelines.